Who Owns Alcon?

Alcon publishes an annual sustainability report under its "Brilliant Planet" environmental framework. As of the 2024 report, 17 of 18 manufacturing sites held ISO 14001:2015 environmental management certification. Approximately 70% of manufacturing sites operate as landfill-free for non-hazardous waste.

Alcon has set targets to reduce absolute Scope 1 and 2 greenhouse gas emissions. The company's 2024 sustainability report documented progress toward these targets but did not claim net-zero certification. No third-party carbon-neutral certification from a body such as Science Based Targets initiative (SBTi) has been confirmed for Alcon's full operations as of May 2025.

Through its "Brilliant Lives" social impact program, Alcon has committed funds and resources to improving vision access in underserved communities. The company reported investing approximately $42 million annually in eye care infrastructure and training in low-income markets.

Alcon's contact lens manufacturing processes use significant volumes of water. The company's sustainability reports document water use by facility but do not claim water-neutral status.

Alcon's Dailies Total1 contact lens received recognition from the American Academy of Optometry at its annual meeting for its water gradient silicone hydrogel technology, which delivers a reported 80% water content at the lens surface. This is a verifiable clinical and technical claim documented in peer-reviewed literature.

Alcon's NGENUITY 3D visualization system has been referenced in peer-reviewed ophthalmology publications as a significant development in vitreoretinal surgery technique, enabling surgeons to operate while viewing a 3D display rather than through an operating microscope eyepiece.

Alcon's PanOptix trifocal intraocular lens was the first trifocal IOL to receive FDA approval for use in the United States, cleared in 2019. This regulatory milestone is a verifiable fact documented in FDA clearance records.

December 2024 Systane recall: Alcon Laboratories issued a voluntary nationwide recall of one lot of Systane Lubricant Eye Drops Ultra PF (Lot 10101) due to potential fungal contamination. The recall was initiated after a consumer complaint identified foreign material inside a sealed single-use vial. The FDA classified the recall and noted that use of contaminated eye drops could cause eye infections that may be vision-threatening. No adverse events were reported at the time of the recall announcement. The affected lot had an expiration date of September 2025.

Aerie Pharmaceuticals drug pricing: Following the 2022 acquisition of Aerie Pharmaceuticals, Alcon assumed the marketing of glaucoma drugs Rocklatan and Rhopressa. Patient advocacy organizations have raised concerns about the pricing of branded glaucoma medications generally, though no specific enforcement action related to these drugs has been announced against Alcon as of May 2025.

Contact lens environmental impact: Industry analysts and environmental researchers have raised concerns about single-use daily contact lens waste, noting that billions of lenses and their packaging are disposed of annually. Alcon is one of the major producers of daily disposable lenses. The company has not announced a formal recycling program for daily disposable lenses in the United States as of May 2025, in contrast to some competitors who have launched such programs.

No major FDA Warning Letters have been issued to Alcon manufacturing facilities as of May 2025, per publicly available FDA inspection records.